Does prostate 5-alpha-reductase convert testosterone to DHT and contribute to bladder-outlet resistance?

The claim describes the established androgen-dependent pathway underlying much of benign prostatic enlargement and its potential contribution to bladder-outlet obstruction. It is particularly relevant to older men, in whom BPH becomes common, but it does not mean that enlargement or urinary symptoms alone prove obstruction.

Mechanistic and tissue evidence

• In normal and BPH prostate, 5-alpha-reductase type 2 (SRD5A2) is a major local route converting testosterone to DHT; SRD5A2 expression correlated strongly with enzyme activity (Spearman r=0.81, 95% CI 0.64–0.91; P<0.0001).
• DHT binds androgen receptors in stromal and epithelial cells more avidly than testosterone, regulating AR-dependent transcription and growth-factor networks, including EGF, KGF, IGF, and TGF-β pathways.
• In cultured human stromal cells, DHT effects on IGF-I and IGF-binding proteins were blocked by AR antagonists. DHT also rapidly activates MMP/EGFR/PLC-IP3/intracellular-calcium signaling in prostatic smooth-muscle/myofibroblast cells.
• These signals support stromal–epithelial remodeling largely through reciprocal paracrine mechanisms, rather than a uniform direct proliferative effect in every prostatic compartment.

Pharmacologic and clinical relevance

• Tissue intervention studies provide strong in-vivo corroboration: dutasteride reduced intraprostatic DHT from 3.23 to 0.209 ng/g (94%; P<0.001), while finasteride reduced DHT about 80–91%.
• In a randomized study, six months of finasteride reduced total prostate volume by 21% and inner-gland epithelium by 55%, consistent with androgen-pathway dependence.
• Stromal and glandular enlargement can compress or distort the prostatic urethra and bladder neck, producing static outlet resistance. Smooth-muscle tone can add a dynamic component.

Clinical interpretation

• Prostate size and urinary symptoms do not reliably quantify obstruction in an individual; pressure–flow testing demonstrates obstruction as high detrusor pressure with low flow.

Bottom line

• The full pathway—local testosterone-to-DHT conversion, AR signaling, prostate growth/remodeling, and potential mechanical outlet resistance—is well supported, with the growth link appropriately understood as context-dependent and partly paracrine.